
Gene Solutions Unveils Less Invasive Prenatal Testing at ISPD 2026
The story in brief
Gene Solutions showcased prenatal and women's genomic health advances at ISPD 2026, presenting a test using liquid-based cervical cytology to reduce invasive procedures while maintaining accuracy. The method identifies pregnancy complication risks, with AI aiding in extracting clinically relevant signals from NIPT data. Global experts gathered to explore genomic medicine opportunities and responsibilities.